RecruitingNot ApplicableNCT05753774

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Functional Gastrointestinal Disorders in Children

Sponsor

Biao Zou

Enrollment

100 participants

Start Date

Aug 1, 2022

Study Type

INTERVENTIONAL

Conditions

Functional Gastrointestinal Disorders

Summary

Safety and efficacy of FMT in Pediatric Functional Gastrointestinal Disorders

Eligibility

Min Age: 1 YearMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Conventional drugs and a biological treatment called FMT for people with functional gastrointestinal disorders. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year to 15 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALFMT

FMT is a technique in which intestinal microbiota are transferred from a healthy screened donor to a patient, with the goal being to introduce or restore a stable microbial community in the gut. FMT was given 1-3courses, 3-6 times per courses

DRUGConventional drugs

Conventional drugs include probiotics and omeprazole, and cyproheptadine and moxapride